GGrantIndex
Sort

50,496 grants matching lung cancer

Transport Oncophysics Core

$448,357
Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA

Metarrestin for the Treatment of Pancreatic Cancer

$448,357
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR

Oxidant Exposure and Related Harm from Tobacco Smoke

$448,326
Joshua E Muscat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · HL

TGF-beta Suppression and Promotion of Mammary Carcinomas

$448,305
Harold L Moses · Vanderbilt University · R01 · FY2012 · CA

Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells

$448,281
Harold E Varmus · Weill Medical Coll Of Cornell Univ · U01 · FY2019 · CA

Role of ATII cell senescence in influenza pathogenesis in aging

$448,270
Ian Christopher Davis · Ohio State University · R21 · FY2023 · AG

Epigenetic Therapy for Thoracic Malignanceis

$448,245
David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA

Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer

$448,182
Louise C Showe · Wistar Institute · U01 · FY2021 · CA

Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer

$448,167
Ming You · Medical College Of Wisconsin · R01 · FY2012 · CA

Analyses of the Molecular Functions for D-Cyclins

$448,113
Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2011 · CA

Evaluation of the Implementation and Effectiveness of the American College of Surgeons Operative Standards Program

$448,059
Lesly A Dossett · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Imaging Habitats in Sarcoma

$448,046
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA

Race/Ethnicity and the Process of Smoking Cessation

$447,999
University Of Texas Md Anderson Can Ctr · R01 · FY2003 · DA

Occupational and Environmental Determinants of Cancer among Women and Minorities

$447,997
Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

NanoOptogenetic immunotherapy for B cell lymphoma

$447,986
Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach

$447,964
David O. Francis · University Of Wisconsin-Madison · R01 · FY2022 · CA

Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes

$447,953
A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

High-risk hepatoblastoma dissemination control by oncogenic NRF2

$447,944
Sarah Elizabeth Woodfield · Baylor College Of Medicine · R01 · FY2024 · CA

TARGETING ART1, A NOVEL IMMUNE CHECKPOINT, FOR THE TREATMENT OF LUNG CANCER

$447,936
Weill Medical College Of Cornell University · · FY2019 · Defense Health Agency

Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis

$447,799
Melanie R Rutkowski · University Of Virginia · R01 · FY2025 · CA

Direct activators of protein phosphatase 2A (PP2A) as novel Alzheimer's Disease (AD) therapeutics

$447,795
Michael Ohlmeyer · Atux Iskay Group Llc · R43 · FY2020 · AG

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

$447,719
Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA

Cancer in adults following in utero and early life exposure to arsenic

$447,717
Craig M Steinmaus · University Of California Berkeley · R01 · FY2014 · ES

Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer

$447,631
Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · R37 · FY2022 · CA

Individually-tailored clinical decision support for management of indeterminate pulmonary nodules

$447,621
Alex Bui · University Of California Los Angeles · R01 · FY2023 · CA